Ignite Creation Date:
2025-12-24 @ 7:52 PM
Ignite Modification Date:
2026-01-02 @ 10:06 AM
Study NCT ID:
NCT07085104
Status:
RECRUITING
Last Update Posted:
2025-07-25
First Post:
2025-07-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Sponsor:
Allogene Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-09
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2032-10
Completion Date Type:
ESTIMATED
First Submit Date:
2025-07-08
First Submit QC Date:
None
Study First Post Date:
2025-07-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-23
Last Update Post Date:
2025-07-25
Last Update Post Date Type:
ACTUAL